These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8853377)

  • 1. CNS actions of serotonin on cardiovascular function: nonadrenergic, noncholinergic mechanisms.
    Dedeoğlu A; Fisher LA
    Am J Physiol; 1996 Sep; 271(3 Pt 2):R569-78. PubMed ID: 8853377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and autonomic mechanisms mediate cardiovascular actions of central serotonin.
    Pérgola PE; Alper RH
    Am J Physiol; 1991 Jun; 260(6 Pt 2):R1188-93. PubMed ID: 2058745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid.
    Aydin C; Yalcin M
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system cardiovascular effects of bombesin in conscious rats.
    Fisher LA; Cave CR; Brown MR
    Am J Physiol; 1985 Apr; 248(4 Pt 2):H425-31. PubMed ID: 3885756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular activation by serotonergic stimulation: role of corticotropin-releasing factor.
    Dedeoğlu A; Fisher LA
    Am J Physiol; 1994 Sep; 267(3 Pt 2):R859-64. PubMed ID: 8092332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system cardiovascular actions of CRF in sinoaortic-denervated rats.
    Overton JM; Davis-Gorman G; Fisher LA
    Am J Physiol; 1990 Mar; 258(3 Pt 2):R596-601. PubMed ID: 2316708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
    Yalcin M; Aydin C
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central serotonin on autonomic control of heart rate in intact and baroreceptor deficient rats.
    Pérgola PE; Alper RH
    Brain Res; 1992 Jun; 582(2):215-20. PubMed ID: 1393542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressor and bradycardic effects of centrally administered relaxin in conscious rats.
    Yang RH; Bunting S; Wyss JM; Berecek KH; Zhang L; Jin H
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):375-81. PubMed ID: 7619350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effect of peripheral injected melittin in normotensive conscious rats: Mediation of the central cholinergic system.
    Yalcin M; Aydin C; Savci V
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):341-7. PubMed ID: 19910175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reduction of the pressor effect of fluoxetine after V1A-vasopressin receptor blockade in the conscious rats].
    Lazartigues E; Costes S; Brefel-Courbon C; Gharib C; Tran MA; Senard JM; Montastruc JL
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):985-9. PubMed ID: 10486651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of serotonin and DP-5-CT in conscious Long-Evans and Brattleboro rats.
    Anderson IK; Ramage AG; Gardiner SM
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R455-63. PubMed ID: 8770148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic inhibition and vasopressin mediation during centrally induced responses to serotonin in rats.
    Inoue A; Buñag RD
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):902-7. PubMed ID: 2484085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of discrete intrahypothalamic and preoptic injections of bradykinin.
    Diz DI; Jacobowitz DM
    Brain Res Bull; 1984 Apr; 12(4):409-17. PubMed ID: 6329484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor effects of noradrenaline injected into the lateral septal area of unanesthetized rats.
    Scopinho AA; Resstel LB; Antunes-Rodrigues J; Corrêa FM
    Brain Res; 2006 Nov; 1122(1):126-34. PubMed ID: 17011526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.